Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-10-24FDA Approved: TRIJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for TRIJARDY XR, a fixed-dose combination of empagliflozin, linagliptin, and metformin hydrochloride…
-
FDA label_change · 2025-10-24FDA Approved: SYNJARDY — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approves a supplemental application for SYNJARDY (empagliflozin and metformin hydrochloride) to update the product labeling.
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: Truway Diagnostic Tools in Primary Care [EARLY_Phase 1]
The document notes that Truway Health is enrolling invitation-only in an early Phase 1 trial of Truway Diagnostic Tools for primary care, fo…
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: South Asians With Type 2 Diabetes at Risk for Depression [NA]
This clinical trial update notes a study examining depression risk among South Asian individuals with Type 2 diabetes. The trial is currentl…
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults [NA]
A clinical trial update describing the adaptation of a digital health tool to improve medication adherence among Latino adults with type 2 d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: Helping Adults With Type 2 Diabetes Use Their Health Data for Healthy Diabetes Self-Management [NA]
The document describes a clinical trial enrolling adults with Type 2 Diabetes Mellitus to study how they can use their health data to suppor…
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO) [Phase 3]
A Phase 3 trial of tirzepatide (LY3298176) in Chinese participants with Type 2 Diabetes has completed, and results have been posted.
-
EMA guidance · 2025-10-21EMA partners with content creators to promote safe and responsible use of GLP-1 medicines
EMA partners with content creators to promote safe and responsible use of GLP-1 medicines through the HealthNotHype campaign, expanding reac…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus [Phase 1]
This is a Phase 1 trial investigating CT-388 in otherwise healthy overweight and obese adults and patients with type 2 diabetes mellitus; th…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin [Phase 3]
A Phase 3 trial comparing orforglipron (LY3502970) to dapagliflozin in adults with type 2 diabetes on metformin has completed; results are n…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring [NA]
This clinical trial update describes a study evaluating whether a community health worker and pharmacist team using continuous glucose monit…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: STrong Relationships to Improve DiabEtes Pilot [NA]
This update describes a Vanderbilt University Medical Center-sponsored pilot clinical trial aimed at improving Type 2 diabetes, with enrollm…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor [Phase 3]
Phase 3 trial of Orforglipron (LY3502970) in adults with type 2 diabetes and inadequate glycemic control on insulin glargine (with or withou…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus [NA]
This document indicates that a clinical trial evaluating Physiologic Insulin Resensitization (PIR) in patients with chronic kidney disease a…
-
FDA approval · 2025-10-17FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for Ozempic to include the oral semaglutide formulation, expanding treatment options to patients…
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India [Phase 4]
This is a Phase 4 clinical trial of LY900014 in adults with type 2 diabetes conducted in India. The study status is completed.
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: The GRoceries Aimed at Increasing Nutrition Study [NA]
The University of Pennsylvania is recruiting participants for a nutrition-focused clinical trial titled 'The GRoceries Aimed at Increasing N…
-
FDA approval · 2025-10-15FDA Approved: LIRAGLUTIDE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
FDA approved a supplemental application for liraglutide from Meitheal Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Effectiveness of Dapagliflozin for Weight Loss [Phase 2, Phase 3]
This clinical trial update reports the effectiveness of dapagliflozin for weight loss in adults with prediabetes, obesity, morbid obesity, a…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk
This completed trial compares tirzepatide and semaglutide for cardiovascular risk in adults with type 2 diabetes and overweight. The study p…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data
A clinical trial update describes a prediction study for the SURPASS-CVOT cardiovascular outcome trial in type 2 diabetes using healthcare c…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims
A completed study that emulates the SUSTAIN6 type 2 diabetes trial using healthcare claims to evaluate outcomes with semaglutide.
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Role of CGMS Usage in Predicting Risk for Hypoglycemia
A completed clinical trial evaluates whether continuous glucose monitoring usage can predict hypoglycemia risk in individuals with Type 2 di…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Managing Type 1 and High Risk Type 2 Diabetes in the Hospital Setting: Glucose as a Vital Sign [NA]
This clinical trial update reports results on hospital management of Type 1 and high-risk Type 2 diabetes, exploring glucose monitoring as a…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment [Phase 1]
Phase 1 clinical trial evaluating care partner–assisted diabetes self-management by linking continuous glucose monitoring with mobile health…